MarketInOut Stock Screener Log In | Sign Up

Avicanna Inc

TSX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:59
Avicanna Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSX
Market Capitalization13.44 mln
Float106 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.27
Borderline

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-15%
Loss-making

ROE

-114
Deeply negative

Business Description

Avicanna is a Canadian biopharmaceutical company focused on developing and selling cannabis-based products for consumer, medical, and pharmaceutical use across Canada and global markets. Its product range spans topical creams, oral drops, and transdermal formats sold under the RHO Phyto brand, alongside targeted treatments for conditions such as chronic pain, skin disorders, and epilepsy. The company also grows and supplies raw cannabinoid ingredients under the Aureus Santa Marta brand and runs MyMedi.ca, a bilingual online platform where patients receive pharmacist support and access to a broad selection of medical cannabis products. Founded in 2016 and based in Toronto, Avicanna works with private and public insurers to support patient reimbursement and partners with a European pharmaceutical firm to advance its proprietary drug delivery technology.

Key Fundamentals

EPS-0.03
ROE-114
RPS0.21
ROIC-25.61
ROA-17.70
Interest Cover-62.26
EBITDA, mln-2.98
EV / EBITDA-7.55
EV / EBIT-6.12
Revenue, mln25.31
EV / Revenue0.89

Quote Details

Last 0.10
Change 0 (0%)
Open 0.105
Volume 501
Turnover 50.1
Average Volume 77,294

Financial Ratios

Pre-Tax Profit Margin-15
Leverage Ratio5.24
Current Ratio0.97
Price / Book1.01
Price / Tangible Book1.05
Debt / Equity0.04
Price / Sales0.49

Financial Strength

Altman Z-Score-4.83
Piotroski F-Score 3 / 9
Beneish M-Score-2.27
Short Ratio0.04

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.76% 8 / 100   
1 Month -4.76% 27 / 100   
2 Months -16.67% 8 / 100   
6 Months -33.33% 5 / 100   
1 Year -61.54% 2 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog